Table of Content

1 Aurora Kinase B Market Overview
1.1 Aurora Kinase B Product Overview
1.2 Aurora Kinase B Market Segment by Type
1.2.1 AZD-2811
1.2.2 CS-2164
1.2.3 Danusertib
1.2.4 Ilorasertib
1.2.5 NMI-900
1.2.6 Others
1.3 Global Aurora Kinase B Market Size by Type
1.3.1 Global Aurora Kinase B Market Size Overview by Type (2018-2034)
1.3.2 Global Aurora Kinase B Historic Market Size Review by Type (2018-2024)
1.3.3 Global Aurora Kinase B Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Aurora Kinase B Sales Breakdown by Type (2018-2024)
1.4.2 Europe Aurora Kinase B Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Aurora Kinase B Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Aurora Kinase B Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Aurora Kinase B Sales Breakdown by Type (2018-2024)
2 Global Aurora Kinase B Market Competition by Company
2.1 Global Top Players by Aurora Kinase B Sales (2018-2024)
2.2 Global Top Players by Aurora Kinase B Revenue (2018-2024)
2.3 Global Top Players by Aurora Kinase B Price (2018-2024)
2.4 Global Top Manufacturers Aurora Kinase B Manufacturing Base Distribution, Sales Area, Product Type
2.5 Aurora Kinase B Market Competitive Situation and Trends
2.5.1 Aurora Kinase B Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Aurora Kinase B Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aurora Kinase B as of 2022)
2.7 Date of Key Manufacturers Enter into Aurora Kinase B Market
2.8 Key Manufacturers Aurora Kinase B Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Aurora Kinase B Status and Outlook by Region
3.1 Global Aurora Kinase B Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Aurora Kinase B Historic Market Size by Region
3.2.1 Global Aurora Kinase B Sales in Volume by Region (2018-2024)
3.2.2 Global Aurora Kinase B Sales in Value by Region (2018-2024)
3.2.3 Global Aurora Kinase B Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Aurora Kinase B Forecasted Market Size by Region
3.3.1 Global Aurora Kinase B Sales in Volume by Region (2024-2034)
3.3.2 Global Aurora Kinase B Sales in Value by Region (2024-2034)
3.3.3 Global Aurora Kinase B Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Aurora Kinase B by Application
4.1 Aurora Kinase B Market Segment by Application
4.1.1 Anaplastic Large Cell Lymphoma
4.1.2 Kidney Cancer
4.1.3 Lung Cancer
4.1.4 Prostate Cancer
4.1.5 Others
4.2 Global Aurora Kinase B Market Size by Application
4.2.1 Global Aurora Kinase B Market Size Overview by Application (2018-2034)
4.2.2 Global Aurora Kinase B Historic Market Size Review by Application (2018-2024)
4.2.3 Global Aurora Kinase B Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Aurora Kinase B Sales Breakdown by Application (2018-2024)
4.3.2 Europe Aurora Kinase B Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Aurora Kinase B Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Aurora Kinase B Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Aurora Kinase B Sales Breakdown by Application (2018-2024)
5 North America Aurora Kinase B by Country
5.1 North America Aurora Kinase B Historic Market Size by Country
5.1.1 North America Aurora Kinase B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Aurora Kinase B Sales in Volume by Country (2018-2024)
5.1.3 North America Aurora Kinase B Sales in Value by Country (2018-2024)
5.2 North America Aurora Kinase B Forecasted Market Size by Country
5.2.1 North America Aurora Kinase B Sales in Volume by Country (2024-2034)
5.2.2 North America Aurora Kinase B Sales in Value by Country (2024-2034)
6 Europe Aurora Kinase B by Country
6.1 Europe Aurora Kinase B Historic Market Size by Country
6.1.1 Europe Aurora Kinase B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Aurora Kinase B Sales in Volume by Country (2018-2024)
6.1.3 Europe Aurora Kinase B Sales in Value by Country (2018-2024)
6.2 Europe Aurora Kinase B Forecasted Market Size by Country
6.2.1 Europe Aurora Kinase B Sales in Volume by Country (2024-2034)
6.2.2 Europe Aurora Kinase B Sales in Value by Country (2024-2034)
7 Asia-Pacific Aurora Kinase B by Region
7.1 Asia-Pacific Aurora Kinase B Historic Market Size by Region
7.1.1 Asia-Pacific Aurora Kinase B Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Aurora Kinase B Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Aurora Kinase B Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Aurora Kinase B Forecasted Market Size by Region
7.2.1 Asia-Pacific Aurora Kinase B Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Aurora Kinase B Sales in Value by Region (2024-2034)
8 Latin America Aurora Kinase B by Country
8.1 Latin America Aurora Kinase B Historic Market Size by Country
8.1.1 Latin America Aurora Kinase B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Aurora Kinase B Sales in Volume by Country (2018-2024)
8.1.3 Latin America Aurora Kinase B Sales in Value by Country (2018-2024)
8.2 Latin America Aurora Kinase B Forecasted Market Size by Country
8.2.1 Latin America Aurora Kinase B Sales in Volume by Country (2024-2034)
8.2.2 Latin America Aurora Kinase B Sales in Value by Country (2024-2034)
9 Middle East and Africa Aurora Kinase B by Country
9.1 Middle East and Africa Aurora Kinase B Historic Market Size by Country
9.1.1 Middle East and Africa Aurora Kinase B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Aurora Kinase B Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Aurora Kinase B Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Aurora Kinase B Forecasted Market Size by Country
9.2.1 Middle East and Africa Aurora Kinase B Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Aurora Kinase B Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AbbVie Inc
10.1.1 AbbVie Inc Company Information
10.1.2 AbbVie Inc Introduction and Business Overview
10.1.3 AbbVie Inc Aurora Kinase B Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AbbVie Inc Aurora Kinase B Products Offered
10.1.5 AbbVie Inc Recent Development
10.2 Advenchen Laboratories LLC
10.2.1 Advenchen Laboratories LLC Company Information
10.2.2 Advenchen Laboratories LLC Introduction and Business Overview
10.2.3 Advenchen Laboratories LLC Aurora Kinase B Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Advenchen Laboratories LLC Aurora Kinase B Products Offered
10.2.5 Advenchen Laboratories LLC Recent Development
10.3 Aeterna Zentaris Inc
10.3.1 Aeterna Zentaris Inc Company Information
10.3.2 Aeterna Zentaris Inc Introduction and Business Overview
10.3.3 Aeterna Zentaris Inc Aurora Kinase B Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Aeterna Zentaris Inc Aurora Kinase B Products Offered
10.3.5 Aeterna Zentaris Inc Recent Development
10.4 Amgen Inc
10.4.1 Amgen Inc Company Information
10.4.2 Amgen Inc Introduction and Business Overview
10.4.3 Amgen Inc Aurora Kinase B Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Amgen Inc Aurora Kinase B Products Offered
10.4.5 Amgen Inc Recent Development
10.5 AstraZeneca Plc
10.5.1 AstraZeneca Plc Company Information
10.5.2 AstraZeneca Plc Introduction and Business Overview
10.5.3 AstraZeneca Plc Aurora Kinase B Sales, Revenue and Gross Margin (2018-2024)
10.5.4 AstraZeneca Plc Aurora Kinase B Products Offered
10.5.5 AstraZeneca Plc Recent Development
10.6 Chipscreen Biosciences Ltd
10.6.1 Chipscreen Biosciences Ltd Company Information
10.6.2 Chipscreen Biosciences Ltd Introduction and Business Overview
10.6.3 Chipscreen Biosciences Ltd Aurora Kinase B Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Chipscreen Biosciences Ltd Aurora Kinase B Products Offered
10.6.5 Chipscreen Biosciences Ltd Recent Development
10.7 Cielo Therapeutics Inc
10.7.1 Cielo Therapeutics Inc Company Information
10.7.2 Cielo Therapeutics Inc Introduction and Business Overview
10.7.3 Cielo Therapeutics Inc Aurora Kinase B Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Cielo Therapeutics Inc Aurora Kinase B Products Offered
10.7.5 Cielo Therapeutics Inc Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi Aurora Kinase B Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sanofi Aurora Kinase B Products Offered
10.8.5 Sanofi Recent Development
10.9 Sareum Holdings Plc
10.9.1 Sareum Holdings Plc Company Information
10.9.2 Sareum Holdings Plc Introduction and Business Overview
10.9.3 Sareum Holdings Plc Aurora Kinase B Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Sareum Holdings Plc Aurora Kinase B Products Offered
10.9.5 Sareum Holdings Plc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Aurora Kinase B Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Aurora Kinase B Industrial Chain Analysis
11.4 Aurora Kinase B Market Dynamics
11.4.1 Aurora Kinase B Industry Trends
11.4.2 Aurora Kinase B Market Drivers
11.4.3 Aurora Kinase B Market Challenges
11.4.4 Aurora Kinase B Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Aurora Kinase B Distributors
12.3 Aurora Kinase B Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of AZD-2811
Table 2. Major Company of CS-2164
Table 3. Major Company of Danusertib
Table 4. Major Company of Ilorasertib
Table 5. Major Company of NMI-900
Table 6. Major Company of Others
Table 7. Global Aurora Kinase B Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Aurora Kinase B Sales by Type (2018-2024) & (K Pcs)
Table 9. Global Aurora Kinase B Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Aurora Kinase B Sales by Type (2018-2024) & (US& Million)
Table 11. Global Aurora Kinase B Market Share in Value by Type (2018-2024)
Table 12. Global Aurora Kinase B Price by Type (2018-2024) & (USD/Pcs)
Table 13. Global Aurora Kinase B Sales by Type (2024-2034) & (K Pcs)
Table 14. Global Aurora Kinase B Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Aurora Kinase B Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Aurora Kinase B Sales Market Share in Value by Type (2024-2034)
Table 17. Global Aurora Kinase B Price by Type (2024-2034) & (USD/Pcs)
Table 18. North America Aurora Kinase B Sales by Type (2018-2024) & (K Pcs)
Table 19. North America Aurora Kinase B Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Aurora Kinase B Sales (K Pcs) by Type (2018-2024)
Table 21. Europe Aurora Kinase B Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Aurora Kinase B Sales (K Pcs) by Type (2018-2024)
Table 23. Asia-Pacific Aurora Kinase B Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Aurora Kinase B Sales (K Pcs) by Type (2018-2024)
Table 25. Latin America Aurora Kinase B Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Aurora Kinase B Sales (K Pcs) by Type (2018-2024)
Table 27. Middle East and Africa Aurora Kinase B Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Aurora Kinase B Sales by Company (2018-2024) & (K Pcs)
Table 29. Global Aurora Kinase B Sales Share by Company (2018-2024)
Table 30. Global Aurora Kinase B Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Aurora Kinase B Revenue Share by Company (2018-2024)
Table 32. Global Market Aurora Kinase B Price by Company (2018-2024) & (USD/Pcs)
Table 33. Global Aurora Kinase B Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Aurora Kinase B Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aurora Kinase B as of 2022)
Table 36. Date of Key Manufacturers Enter into Aurora Kinase B Market
Table 37. Key Manufacturers Aurora Kinase B Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Aurora Kinase B Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global Aurora Kinase B Sales by Region (2018-2024) & (K Pcs)
Table 41. Global Aurora Kinase B Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Aurora Kinase B Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Aurora Kinase B Sales Market Share in Value by Region (2018-2024)
Table 44. Global Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 45. Global Aurora Kinase B Sales by Region (2024-2034) & (K Pcs)
Table 46. Global Aurora Kinase B Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Aurora Kinase B Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Aurora Kinase B Sales Market Share in Value by Region (2024-2034)
Table 49. Global Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 50. Global Aurora Kinase B Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global Aurora Kinase B Sales by Application (2018-2024) & (K Pcs)
Table 52. Global Aurora Kinase B Sales Market Share in Volume by Application (2018-2024)
Table 53. Global Aurora Kinase B Sales by Application (2018-2024) & (US$ Million)
Table 54. Global Aurora Kinase B Sales Market Share in Value by Application (2018-2024)
Table 55. Global Aurora Kinase B Price by Application (2018-2024) & (USD/Pcs)
Table 56. Global Aurora Kinase B Sales by Application (2024-2034) & (K Pcs)
Table 57. Global Aurora Kinase B Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Aurora Kinase B Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Aurora Kinase B Sales Market Share in Value by Application (2024-2034)
Table 60. Global Aurora Kinase B Price by Application (2024-2034) & (USD/Pcs)
Table 61. North America Aurora Kinase B Sales by Application (2018-2024) (K Pcs)
Table 62. North America Aurora Kinase B Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe Aurora Kinase B Sales by Application (2018-2024) (K Pcs)
Table 64. Europe Aurora Kinase B Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Aurora Kinase B Sales by Application (2018-2024) (K Pcs)
Table 66. Asia-Pacific Aurora Kinase B Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America Aurora Kinase B Sales by Application (2018-2024) (K Pcs)
Table 68. Latin America Aurora Kinase B Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Aurora Kinase B Sales by Application (2018-2024) (K Pcs)
Table 70. Middle East and Africa Aurora Kinase B Sales by Application (2018-2024) & (US$ Million)
Table 71. North America Aurora Kinase B Sales by Country (2018-2024) & (K Pcs)
Table 72. North America Aurora Kinase B Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Aurora Kinase B Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Aurora Kinase B Sales Market Share in Value by Country (2018-2024)
Table 75. North America Aurora Kinase B Sales by Country (2024-2034) & (K Pcs)
Table 76. North America Aurora Kinase B Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Aurora Kinase B Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Aurora Kinase B Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Aurora Kinase B Sales by Country (2018-2024) & (K Pcs)
Table 80. Europe Aurora Kinase B Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Aurora Kinase B Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Aurora Kinase B Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Aurora Kinase B Sales by Country (2024-2034) & (K Pcs)
Table 84. Europe Aurora Kinase B Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Aurora Kinase B Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Aurora Kinase B Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Aurora Kinase B Sales by Region (2018-2024) & (K Pcs)
Table 88. Asia-Pacific Aurora Kinase B Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Aurora Kinase B Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Aurora Kinase B Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Aurora Kinase B Sales by Region (2024-2034) & (K Pcs)
Table 92. Asia-Pacific Aurora Kinase B Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Aurora Kinase B Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Aurora Kinase B Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Aurora Kinase B Sales by Country (2018-2024) & (K Pcs)
Table 96. Latin America Aurora Kinase B Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Aurora Kinase B Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Aurora Kinase B Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Aurora Kinase B Sales by Country (2024-2034) & (K Pcs)
Table 100. Latin America Aurora Kinase B Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Aurora Kinase B Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Aurora Kinase B Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Aurora Kinase B Sales by Country (2018-2024) & (K Pcs)
Table 104. Middle East and Africa Aurora Kinase B Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Aurora Kinase B Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Aurora Kinase B Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Aurora Kinase B Sales by Country (2024-2034) & (K Pcs)
Table 108. Middle East and Africa Aurora Kinase B Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Aurora Kinase B Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Aurora Kinase B Sales Market Share in Value by Country (2024-2034)
Table 111. AbbVie Inc Company Information
Table 112. AbbVie Inc Introduction and Business Overview
Table 113. AbbVie Inc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 114. AbbVie Inc Aurora Kinase B Product
Table 115. AbbVie Inc Recent Development
Table 116. Advenchen Laboratories LLC Company Information
Table 117. Advenchen Laboratories LLC Introduction and Business Overview
Table 118. Advenchen Laboratories LLC Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 119. Advenchen Laboratories LLC Aurora Kinase B Product
Table 120. Advenchen Laboratories LLC Recent Development
Table 121. Aeterna Zentaris Inc Company Information
Table 122. Aeterna Zentaris Inc Introduction and Business Overview
Table 123. Aeterna Zentaris Inc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 124. Aeterna Zentaris Inc Aurora Kinase B Product
Table 125. Aeterna Zentaris Inc Recent Development
Table 126. Amgen Inc Company Information
Table 127. Amgen Inc Introduction and Business Overview
Table 128. Amgen Inc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 129. Amgen Inc Aurora Kinase B Product
Table 130. Amgen Inc Recent Development
Table 131. AstraZeneca Plc Company Information
Table 132. AstraZeneca Plc Introduction and Business Overview
Table 133. AstraZeneca Plc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 134. AstraZeneca Plc Aurora Kinase B Product
Table 135. AstraZeneca Plc Recent Development
Table 136. Chipscreen Biosciences Ltd Company Information
Table 137. Chipscreen Biosciences Ltd Introduction and Business Overview
Table 138. Chipscreen Biosciences Ltd Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 139. Chipscreen Biosciences Ltd Aurora Kinase B Product
Table 140. Chipscreen Biosciences Ltd Recent Development
Table 141. Cielo Therapeutics Inc Company Information
Table 142. Cielo Therapeutics Inc Introduction and Business Overview
Table 143. Cielo Therapeutics Inc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 144. Cielo Therapeutics Inc Aurora Kinase B Product
Table 145. Cielo Therapeutics Inc Recent Development
Table 146. Sanofi Company Information
Table 147. Sanofi Introduction and Business Overview
Table 148. Sanofi Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 149. Sanofi Aurora Kinase B Product
Table 150. Sanofi Recent Development
Table 151. Sareum Holdings Plc Company Information
Table 152. Sareum Holdings Plc Introduction and Business Overview
Table 153. Sareum Holdings Plc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 154. Sareum Holdings Plc Aurora Kinase B Product
Table 155. Sareum Holdings Plc Recent Development
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Aurora Kinase B Market Trends
Table 159. Aurora Kinase B Market Drivers
Table 160. Aurora Kinase B Market Challenges
Table 161. Aurora Kinase B Market Restraints
Table 162. Aurora Kinase B Distributors List
Table 163. Aurora Kinase B Downstream Customers
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Aurora Kinase B Product Picture
Figure 2. Global Aurora Kinase B Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Aurora Kinase B Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Aurora Kinase B Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of AZD-2811
Figure 6. Global AZD-2811 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of CS-2164
Figure 8. Global CS-2164 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Danusertib
Figure 10. Global Danusertib Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Ilorasertib
Figure 12. Global Ilorasertib Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of NMI-900
Figure 14. Global NMI-900 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Global Aurora Kinase B Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global Aurora Kinase B Sales Market Share by Type in 2022 & 2034
Figure 19. North America Aurora Kinase B Sales Market Share in Volume by Type in 2022
Figure 20. North America Aurora Kinase B Sales Market Share in Value by Type in 2022
Figure 21. Europe Aurora Kinase B Sales Market Share in Volume by Type in 2022
Figure 22. Europe Aurora Kinase B Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Aurora Kinase B Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Aurora Kinase B Sales Market Share in Value by Type in 2022
Figure 25. Latin America Aurora Kinase B Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Aurora Kinase B Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Aurora Kinase B Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Aurora Kinase B Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Aurora Kinase B Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Aurora Kinase B Revenue in 2022
Figure 31. Aurora Kinase B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Anaplastic Large Cell Lymphoma
Figure 33. Global Anaplastic Large Cell Lymphoma Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Kidney Cancer
Figure 35. Global Kidney Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Lung Cancer
Figure 37. Global Lung Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Prostate Cancer
Figure 39. Global Prostate Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Product Picture of Others
Figure 41. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 42. Global Aurora Kinase B Sales by Application (2018-2034) & (US$ Million)
Figure 43. Global Aurora Kinase B Sales Market Share by Application in 2022 & 2034
Figure 44. North America Aurora Kinase B Sales Market Share in Volume by Application in 2022
Figure 45. North America Aurora Kinase B Sales Market Share in Value by Application in 2022
Figure 46. Europe Aurora Kinase B Sales Market Share in Volume by Application in 2022
Figure 47. Europe Aurora Kinase B Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific Aurora Kinase B Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific Aurora Kinase B Sales Market Share in Value by Application in 2022
Figure 50. Latin America Aurora Kinase B Sales Market Share in Volume by Application in 2022
Figure 51. Latin America Aurora Kinase B Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa Aurora Kinase B Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. Aurora Kinase B Manufacturing Cost Structure
Figure 55. Aurora Kinase B Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed